Trial site
Suzhou
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Multiple sclerosis3 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Lupus (SLE)2 trials
- Metastatic breast cancer2 trials
- Stroke2 trials
- Migraine1 trial
- Myasthenia gravis1 trial
- Myelodysplastic syndromes1 trial
- Psoriasis1 trial
- Phase
- Phase 312 trials
- Phase 43 trials
- Phase 22 trials
- Status
- Active, not recruiting7 trials
- Completed7 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
Completed
Completed
Completed
Terminated
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026